Estrogen receptor ligands. Part 8: Dihydrobenzoxathiin SERAMs with heteroatom-substituted side chains

TA Blizzard, F DiNinno, JD Morgan, JY Wu…

Index: Bioorganic and Medicinal Chemistry Letters, , vol. 14, # 15 p. 3865 - 3868

Full Text: HTML

Citation Number: 25

Abstract

... Bioorganic & Medicinal Chemistry Letters. Volume 14, Issue 15, 2 August 2004, Pages 3865–3868. Cover image Cover image. Estrogen receptor ligands. Part 8: Dihydrobenzoxathiin SERAMs with heteroatom-substituted side chains. ...

Related Articles:

Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl) methyl] piperidine series of histamine H 3 receptor antagonists

[Berlin, Michael; Ting, Pauline C.; Vaccaro, Wayne D.; Aslanian, Robert; McCormick, Kevin D.; Lee, Joe F.; Albanese, Margaret M.; Mutahi, Mwangi W.; Piwinski, John J.; Shih, Neng-Yang; Duguma, Luli; Solomon, Daniel M.; Zhou, Wei; Sher, Rosy; Favreau, Leonard; Bryant, Matthew; Korfmacher, Walter A.; Nardo, Cymbelene; West Jr., Robert E.; Anthes, John C.; Williams, Shirley M.; Wu, Ren-Long; Susan She; Rivelli, Maria A.; Corboz, Michel R.; Hey, John A. Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 4 p. 989 - 994]

Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl) methyl] piperidine series of histamine H 3 receptor antagonists

[Bioorganic and Medicinal Chemistry Letters, , vol. 16, # 4 p. 989 - 994]

More Articles...